T Gaiser
Overview
Explore the profile of T Gaiser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hofheinz R, Herrle F, Dechow T, von Weikersthal L, Welslau M, Lettmaier S, et al.
ESMO Open
. 2025 Feb;
10(2):104095.
PMID: 39986704
No abstract available.
2.
Seidel S, Ahmadi S, Weihermuller L, Couedel A, Lopez G, Behrend D, et al.
Sci Total Environ
. 2024 Oct;
955:176738.
PMID: 39389147
Process-based soil-crop models are becoming increasingly important to estimate the effects of agricultural management practices and climate change impacts on soil organic carbon (C). Although work has been done on...
3.
Hofheinz R, Herrle F, Dechow T, von Weikersthal L, Welslau M, Lettmaier S, et al.
ESMO Open
. 2024 Sep;
9(9):103703.
PMID: 39260162
Background: Neoadjuvant chemotherapy is an option for patients with locally advanced rectal cancer at low risk for local recurrence. This randomized phase II trial investigated whether the addition of aflibercept...
4.
Baretton G, Lordick F, Gaiser T, Hofheinz R, Horst D, Lorenzen S, et al.
Pathologie (Heidelb)
. 2024 Jan;
45(1):51-58.
PMID: 38170268
As a result of the high approval dynamics and the growing number of immuno-oncological therapy concepts, the complexity of therapy decisions and control in the area of carcinomas of the...
5.
Baretton G, Lordick F, Gaiser T, Hofheinz R, Horst D, Lorenzen S, et al.
J Cancer Res Clin Oncol
. 2023 Oct;
149(17):16231-16238.
PMID: 37874352
As a result of the high approval dynamics and the growing number of immuno-oncological concepts, the complexity of treatment decisions and control in the area of cancers of the esophagus,...
6.
Rodriguez A, Ruiz-Ramos M, Palosuo T, Carter T, Fronzek S, Lorite I, et al.
Agric For Meteorol
. 2019 Apr;
264:351-362.
PMID: 31007324
Climate change is expected to severely affect cropping systems and food production in many parts of the world unless local adaptation can ameliorate these impacts. Ensembles of crop simulation models...
7.
Hirsch D, Gaiser T
Pathologe
. 2018 Sep;
39(Suppl 2):253-261.
PMID: 30229283
Background: Patients with inflammatory bowel diseases, i. e., ulcerative colitis and Crohn's disease (CD), face an increased risk of developing colorectal cancer (CRC). Evidence, mainly from ulcerative colitis, suggests that...
8.
Tagkalos E, Heimann A, Gaiser T, Hirsch D, Gockel I, Lang H, et al.
J Invest Surg
. 2018 May;
33(1):59-66.
PMID: 29775392
: Bipolar sealing devices are routinely used to seal blood vessels. The aim of the study is to evaluate the feasibility and safety of colonic sealing with the use of...
9.
Feng T, Dzieran J, Yuan X, Dropmann A, Maass T, Teufel A, et al.
Oncogenesis
. 2017 Jan;
6(1):e294.
PMID: 28134936
TGF-β signaling in liver cells has variant roles in the dynamics of liver diseases, including hepatocellular carcinoma (HCC). We previously found a correlation of high levels of the important endogenous...
10.
Lordick F, Al-Batran S, Hofheinz R, Lorenzen S, Thuss-Patience P, Baretton G, et al.
Z Gastroenterol
. 2016 Aug;
54(8):791-6.
PMID: 27529529
Valid HER2 testing is essential for optimal therapy of patients with HER2 positive gastric cancer and the correct use of first-line treatment. While each breast cancer is routinely being tested...